Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing propoxyphene napsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paracetamol and propoxyphene napsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate monohydrate (substance) |
Is a |
False |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate monohydrate (substance) |
Is modification of (attribute) |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
Has precise active ingredient |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Dextropropoxyphene napsylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |